elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Dapagliflozin
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Dapagliflozin
RIS
0.001
(Research Intensity Score)
Papers
138
Top papers
Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
2023 · 119 citations
Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study
2025 · 18 citations
Sodium-Glucose Cotransporter 2 Inhibitors, Erythrocytosis, and Thrombosis in Adults With Type 2 Diabetes
2025 · 18 citations
Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors
2025 · 20 citations
Dapagliflozin and ventilatory control during exercise in heart failure with preserved ejection fraction: the CAMEO-DAPA trial
2025 · 17 citations
Zirconium nanoparticles decorated chitosan@hematoxylin/pencil graphite as a novel voltammetric sensor for monitoring of linagliptin/dapagliflozin co-therapy
2025 · 12 citations
Modular and Stereoselective Synthesis of C-Aryl Glycosides via Catellani Reaction
2020 · 154 citations
Anthracycline- and HER2-induced cardiotoxicity: mechanisms, current strategies, and the emerging role of dapagliflozin as a targeted cardioprotective agent
2025 · 8 citations
Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ 1–42 -induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease
2025 · 12 citations
Newest papers
Dapagliflozin-associated correction of acute amphotericin B-induced hypomagnesemia
2026 · 1 citations
Effects of Dapagliflozin on the Bone of Patients with CKD on Dialysis
2026
SGLT2 inhibitors and secondary polycythemia: a systematic review and meta-analysis of hematologic effects in patients with type 2 diabetes
2026
Adoption and diffusion of SGLT2 inhibitors among cardiologists in medicare part D, 2019–2023: a provider-level observational study
2026
Metabolic remodeling and cardiac functional adaptation mediated by dapagliflozin in patients with acute heart failure: a retrospective cohort study
2026
Association between different sodium–glucose co-transporter 2 inhibitors and the risk of dementia: a network meta-analysis
2026
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Hemoglobinand Hematocrit: A Retrospective Analysis (SGLT-2 Inhibitors &Hemoconcentration)
2026
Dapagliflozin ameliorates Alzheimer’s disease in rats via stimulating the protective arm of renin angiotensin system and suppressing neuroinflammation
2026
Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage
2026
Browse all papers →
Dapagliflozin's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Dapagliflozin's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link